Skip to main content
. 2023 Sep 28;299(11):105297. doi: 10.1016/j.jbc.2023.105297

Table 2.

Plasmids used in the study

Name Description Reference
PC1441 YCp50-STE11-4 (133)
PC1696 pMsb2-GFP (85)
PC1715 pRS316-SHO1(P120L)-GFP (85)
PC2150 pRS316-CDC24 (28)
PC1422 pRS315 (124)
PC2769 pV84 (134)
PC2107 pCDC24-lacZ This study
PC2207 pRS316 (124)
PC4394 pRL116 CEN/URA3 GFP-Ste20 (35)
PC4395 pRL116 CEN/URA3 GFP-Ste20334-369Δ (CRIBΔ) (35)
PC6455 pRS306-GFP-linker-CDC42 (pDLB3609) (34)
PC6454 pRS316-GFP-linker-CDC42 (29)
PC6457 pRS315-GFP-linker-CDC42 (29)
PC7458 pRS316-GFP-linker-CDC42 (Q61L) (65)
PC7654 pRS316-GFP-linker-CDC42 (Q61L+ TD: K5R, Q61L, K94R, K96R) (65)
PC3621 pSW17 control plasmid (99)
PC3622 pSW72 CDC24 (99)
PC3623 pSW76 CDC24 with PH-A and Linker A mutations (99)
PC3624 pSW78 CDC24 with PH-A mutations (99)
PC3625 pSW80 CDC24 with Linker A mutations (99)
PC3626 pSW82 CDC24 with T35A mutations (99)
PC7670a pRS316-GFP-linker-CDC42 (V36T) This study
a

The pBMH1 and pBMH2 plasmids are driven by the GAL1 promoter and have been described in (90).